- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
- Video consultations
Last updated: 3 Sep 2020
Dr Nik Kamperidis is a luminal gastroenterologist with a specialist interest in Inflammatory Bowel Disease (IBD).
He qualified from the Aristotle University in Greece in 2003. He undertook specialist training in London and Kent, Surrey and Sussex and an advanced endoscopy fellowship at St Mark’s Hospital.
He has completed postgraduate studies and has been awarded an MSc degree and an MD (Res) from Barts and The London School of Medicine. His research has been on Inflammatory Bowel Disease and his thesis on “Nutrient effects in Inflammatory Bowel Disease” focused on the effect of enteral diets in Crohn’s disease. He had the opportunity to present his research in national and international conferences, win awards and publish articles in peer reviewed journals. His current research focuses on treatment optimisation of novel therapies and improvement in quality of care for patients with IBD.
As a consultant his clinical work involves most aspects of luminal gastroenterology with key interest areas the investigation and management of Inflammatory Bowel Disease and Endoscopy.
Areas of interest
Inflammatory Bowel Disease;
Irritable Bowel Syndrome;
Current NHS consultant posts held
St Mark's Hospital and Academic Institute
Inflammatory Bowel Disease
Quality of care
(Additional) Languages spoken
- Greek, Modern - Fluent
- French - Basic
1.Impact of Therapeutic Drug level monitoring on outcomes of patients with Crohn’s Disease treated with Infliximab: real world data from a retrospective single centre cohort study.
N Kamperidis, P Middleton, T Tyrrell, I Stasinos, N Arebi
Frontline Gastroetnerology, 2019
2.Monitoring of biologics in Inflammatory Bowel Disease (IBD) patients using the Patients Know Best electronic portal: Pilot study of update, acceptability and outcomes.
N Kamperidis, M O’Connor, N Arebi
Gastrointestinal Nursing, 2018
3. Effectiveness and safety of Vedolizumab in anti-TNF naïve patients with Iinflammatory Bowel Disease – A multicentre retrospective European study.
Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M
Inflammatory Bowel Disease, 2018
4. The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery.
Kamperidis N, Faiz O, Arebi N.
Annals of Surgery, 2017
5. Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.
Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM, Direkze N, Langmead L, Irving PM, Rampton DS, Lindsay JO.
Alimentary Pharmacology Therapeutics, 2013
6. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent.
Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL, Lindsay JO, Rampton DS.
Alimentary Pharmacology Therapeutics, 2012
7. Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease.
Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM, Langmead FL, Irving PM, Rampton DS, Lindsay JO.
Journal of Pediatric Gastroenterology and Nutrition, 2012
8. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease.
Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS.
Inflamm Bowel Dis. 2012
- MSc Barts and The London School of Medicine 2006
- MD(Res) Barts and The London School of Medicine 2016
Reference number 6101086
Details of entry to specialist register
- On Specialty Register for Gastroenterology and Internal Medicine, 2018
Affiliations / memberships
Member of The Royal College of Physicians
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Other ways of contacting me
I can be contacted directly using Skype. My Skype ID is: nkamperidis